Metraipolis › archive › dc_c311840f2dbe

Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China — Europe PMC PMID:41394150

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41394150
DOI
10.3389/fphar.2025.1684966
License (as archived)
solo-consultazione
Archived
2026-11-08T04:36:12.463Z
SHA-256 of the archived text
9c91f0f39a14e9c6ca5a990f98775eaeabf0cf54c3c7125ba6f632d378a421ed
Stable URL of this page
https://metraipolis.com/documento/dc_c311840f2dbe

How to cite

Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China — Europe PMC PMID:41394150 — Europe PMC (en), https://europepmc.org/article/MED/41394150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c311840f2dbe (Metraipolis archive dc_c311840f2dbe, sha256 9c91f0f39a14e9c6ca5a990f98775eaeabf0cf54c3c7125ba6f632d378a421ed)
BibTeX
@misc{dcc311840f2dbe,
  title = {Cost-effectiveness analysis of eight first-line treatments for metastatic hormone-sensitive prostate cancer in China — Europe PMC PMID:41394150},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41394150},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c311840f2dbe; sha256 9c91f0f39a14e9c6ca5a990f98775eaeabf0cf54c3c7125ba6f632d378a421ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41394150. Agents can read the archived copy with the MCP tool read_document.